Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture. While there are positive aspects like strong demand in AI-related applications and stable revenue in healthcare, there are concerns about rising SG&A expenses and declining EBITDA margin. The Q&A reveals cautious optimism with mid-single-digit growth expectations and price adjustments to counter cost pressures. However, uncertainties around share gains, M&A, and memory pricing impact add ambiguity. Given the company's market cap and the balanced positives and negatives, the stock price is likely to remain neutral, with limited short-term movement.
Fourth Quarter Revenue $801 million, slightly above the midpoint of guidance of $790 million and 1.3% higher than the third quarter. Year-over-year, revenue increased 12%, driven by an 11% increase in volume and a 3% benefit from favorable foreign currency, partially offset by a 1% decline in average selling prices. The sequential increase was driven by growing broad-based business in Industrial Power and AI-related power applications.
Automotive Revenue Decreased 3.4% versus the third quarter, mostly related to lower pull rates during the end of December holiday weeks in the Americas and Europe. However, Asia automotive revenue grew in a seasonally strong quarter. Orders for the quarter grew in each region due to capacity readiness and new opportunities with OEMs and Tier 1s.
Industrial Power Revenue Increased 3.2%, driven by increasing shipments of high-voltage DC power capacitors to smart grid infrastructure projects, multiproduct inventory replenishment, and strengthening market demand for building security power requirements and new industrial programs ramping up.
Aerospace-Defense Revenue Slightly down 1.2%, reflecting the impact of the U.S. government shutdown on billings and some project delays in Europe. Orders increased with strong demand, particularly for capacitors.
Healthcare Revenue Flat compared to the third quarter. Revenue declined in the Americas and Asia but Europe had its strongest quarter in 3 years due to demand for hearing aids, implantables, and diagnostic equipment. Bookings increased.
Other Revenue (AI-related applications) Grew 10.6% versus the third quarter, primarily due to customers ramping up production for new products to support AI power management applications. Order intake grew due to increased production of AI servers and extended component lead times across the industry.
Gross Profit $157 million, resulting in a gross margin of 19.6%, modestly above both the midpoint of guidance and the third quarter. Year-over-year, gross margin improved due to higher volumes, which helped offset continued pressure from elevated metals and material costs.
SG&A Expenses $142 million, compared to $135 million in the third quarter. The increase was primarily due to higher compensation costs, higher R&D spending, and legal costs and fees related to accounts receivable securitization transactions.
EBITDA $70 million for an EBITDA margin of 8.8%, down from 9.6% in the third quarter.
Free Cash Flow $55 million, reflecting high capital expenditures partially offset by the securitization of accounts receivable, compared to a negative $24 million in the third quarter.
Revenue from new AI-related power applications: Sequential increase in revenue driven by growing business in Industrial Power and AI-related power applications.
New product designs: Released 8 Gen 2 1,200-volt Planar MOSFETs for industrial use and first trench MOSFET, the silicon carbide Gen 3 1,200 volts for industrial and automotive applications.
Reference designs: Released 3 new reference designs, including eFuse designs and an isolated current sensor for high-voltage applications.
Geographical revenue growth: Revenue growth driven entirely by Asia, which grew 3.6%, while the Americas and Europe remained flat.
Market share gains: Gained market share in Industrial Power, Automotive, Aerospace-Defense, AI Computing, and Healthcare markets, representing 95% of core business.
Customer reengagement: Reengaged with previously underserved and inactive customers, gaining orders and developing new customer relationships.
Capacity expansion: Heavy investment over the past 3 years to expand capacity for high-growth, high-profit products.
Operational readiness: Maintained capacity readiness to meet urgent supply needs of automotive OEMs and Tier 1s.
Inventory management: Improved inventory days outstanding to 107 days and reduced distribution inventory to 22 weeks.
Vishay 3.0 strategic plan: Focused on faster revenue growth, profitability, and enhanced capital returns through capacity expansion, innovation, and customer engagement.
Silicon carbide strategy: Released advanced silicon carbide trench MOSFETs for automotive and AI applications, positioning for 800-volt applications.
Subcontractor initiative: Qualified over 10,000 part numbers, broadening product portfolio and increasing share of customers' bill of materials.
Automotive Revenue Decrease: Automotive revenue decreased 3.4% in Q4 due to lower pull rates during holiday weeks in the Americas and Europe, despite growth in Asia. This reflects potential risks in regional demand fluctuations and seasonality.
Aerospace-Defense Revenue Decline: Revenue in Aerospace-Defense was down 1.2% due to the U.S. government shutdown and delayed projects in Europe, highlighting risks tied to geopolitical and governmental factors.
Healthcare Revenue Volatility: Healthcare revenue was flat, with declines in the Americas and Asia, and fluctuations tied to customer program milestones. This indicates risks in demand consistency and dependency on specific program timelines.
Newport Facility Drag: The Newport fab negatively impacted gross margins by 130 basis points in Q4, with ongoing challenges in ramping up production and customer audits, posing risks to profitability and operational efficiency.
Elevated Input Costs: Continued pressure from elevated metals and material costs impacted gross margins, reflecting risks from supply chain and raw material price volatility.
Extended Lead Times: Extended lead times for diodes and MOSFETs in Asia and the Americas could strain customer relationships and operational efficiency, posing risks to meeting demand.
CapEx and Cash Flow Constraints: High capital expenditures for capacity expansion, including delays in equipment delivery, are straining free cash flow, with negative free cash flow expected for 2026. This poses financial risks and limits flexibility.
Geopolitical and Regional Risks: The U.S. government shutdown and European project delays impacted Aerospace-Defense revenue, while Asia's growth is heavily reliant on AI demand, indicating risks tied to geopolitical and regional dependencies.
Customer Dependency and Program Risks: Revenue in Healthcare and Aerospace-Defense is tied to specific customer programs and government funding, posing risks from dependency on external timelines and approvals.
5-year strategic plan: Focus on driving faster revenue growth, raising profitability, and enhancing capital returns through capacity expansion, customer engagement, and innovation.
Capacity expansion: Planned CapEx of $400 million to $440 million in 2026, with a focus on investments in the 12-inch fab and other facilities. Peak spending expected in the first half of 2026.
Customer engagement: Reengaging lost customers, attracting new customers, and strengthening relationships with existing ones to drive growth.
Innovation: Release of new silicon carbide Gen 3 trench MOSFETs for industrial and automotive applications, along with new reference designs to promote Vishay products.
Revenue guidance for Q1 2026: Expected to be between $800 million and $830 million, with growth in key segments like Automotive, Industrial Power, Healthcare, Aerospace and Defense, and AI Computing.
Gross margin guidance for Q1 2026: Expected to be 19.9%, plus or minus 50 basis points, including impacts from tariffs and input costs.
CapEx for 2026: Planned spending of $400 million to $440 million, with a focus on capacity expansion projects, particularly in the 12-inch fab.
Customer demand and backlog: Solid book-to-bill ratio of 1.2, with backlog development supporting revenue growth each quarter in 2026.
Market trends: Positive demand trends in Automotive, Industrial Power, Aerospace-Defense, AI Computing, and Healthcare, with customers ramping up production of new projects.
Quarterly Dividend: $13.6 million was distributed as a quarterly dividend in the fourth quarter.
Share Repurchase: No shares were repurchased during the fourth quarter.
Stockholder Return Policy: The company aims to return at least 70% of free cash flow to stockholders through dividends and stock repurchases. However, for 2026, negative free cash flow is expected due to capacity expansion plans.
The earnings call presents a mixed picture. While there are positive aspects like strong demand in AI-related applications and stable revenue in healthcare, there are concerns about rising SG&A expenses and declining EBITDA margin. The Q&A reveals cautious optimism with mid-single-digit growth expectations and price adjustments to counter cost pressures. However, uncertainties around share gains, M&A, and memory pricing impact add ambiguity. Given the company's market cap and the balanced positives and negatives, the stock price is likely to remain neutral, with limited short-term movement.
The earnings call presented mixed signals: revenue and EBITDA improved, but gross margins and book-to-bill ratios were slightly concerning. The Q&A highlighted management's uncertainty on key issues like export restrictions and margin impacts, while also noting no share buybacks due to liquidity constraints. However, the positive revenue growth and margin expansion outlook for 2025, along with improved cash flow, provide a balanced view. Considering the market cap, the stock is likely to experience minimal movement, resulting in a neutral sentiment prediction.
The earnings call reveals strong financial performance across multiple segments, with record high revenues in sectors like AI and industrials. The management's guidance is optimistic, expecting improved margins and a stronger second half of the year. Despite negative free cash flow due to capacity expansion, the strategic focus on growth and customer expansion in AI is promising. The Q&A session supports this positive outlook, highlighting corrected inefficiencies and expanding AI customer base with major tech companies. Given the market cap, the stock is likely to react positively, with a projected increase of 2% to 8%.
The earnings call presented a mix of positive and negative indicators. While the book-to-bill ratio and stockholder returns are positive, revenue and gross profit declines, alongside unclear guidance on AI business size, are concerning. The Q&A session highlighted some optimism for future quarters, but economic uncertainties and flat revenue in key regions temper expectations. With a market cap over $3 billion, the stock's movement is likely to be less volatile. Overall, the sentiment is neutral, with a potential range of -2% to 2% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.